PROMOTING ACCOUNTABILITY, TRANSPARENCY, INNOVATION, EFFICIENCY, AND TIMELINESS AT FDA (PATIENTS FDA) ACT

Remarks in Senate

Enact (S. 2292), S4616, S4625 [26JN]